Trauma equals danger-damage control by the immune system

Journal of Leukocyte Biology

Volumn 92, Issue 3, 2012, Pages 539-551

  Stoecklein, Veit M ^a   Osuka, Akinori ^a   Lederer, James A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; CD4 ANTIGEN; CYTOKINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOREACTIVITY; INJURY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; VACCINATION;

ANIMALS; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; WOUNDS AND INJURIES;

EID: 84865455765     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0212072     Document Type: Review

References (180)

1. Novotny, A. R., Reim, D., Assfalg, V., Altmayr, F., Friess, H. M., Emmanuel, K., Holzmann, B. (2012) Mixed antagonist response and sepsis severity-dependent dysbalance of pro-and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 217, 616-621.
2. Osuchowski, M. F., Welch, K., Siddiqui, J., Remick, D. G. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967-1974.
3. Bone, R. C. (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24, 1125-1128.
4. Moore, F. A., Moore, E. E., Read, R. A. (1993) Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horiz. 1, 538-549.
5. Fan, J., Marshall, J. C., Jimenez, M., Shek, P. N., Zagorski, J., Rotstein, O. D. (1998) Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J. Immunol. 161, 440-447.
6. Fan, J., Kapus, A., Li, Y. H., Rizoli, S., Marshall, J. C., Rotstein, O. D. (2000) Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am. J. Respir. Cell Mol. Biol. 22, 412-421.
7. Papia, G., Fan, J., Kapus, A., Szaszi, K., Marshall, J. C., Tawadros, P., Ailenberg, M., Rotstein, O. D. (2011) Altered inhibitory κβα expression in LPS-stimulated alveolar macrophages following resuscitated hemorrhagic shock. Shock 35, 171-177.
8. Paterson, H. M., Murphy, T. J., Purcell, E. J., Shelley, O., Kriynovich, S. J., Lien, E., Mannick, J. A., Lederer, J. A. (2003) Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J. Immunol. 171, 1473-1483.
9. Maung, A. A., Fujimi, S., MacConmara, M. P., Tajima, G., McKenna, A. M., Delisle, A. J., Stallwood, C., Onderdonk, A. B., Mannick, J. A., Lederer, J. A. (2008) Injury enhances resistance to Escherichia coli infection by boosting innate immune system function. J. Immunol. 180, 2450-2458.
10. Moss, N. M., Gough, D. B., Jordan, A. L., Grbic, J. T., Wood, J. J., Ro-drick, M. L., Mannick, J. A. (1988) Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery 104, 882-887.
11. Shelley, O., Murphy, T., Paterson, H., Mannick, J. A., Lederer, J. A. (2003) Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 20, 123-129.
12. Puyana, J. C., Pellegrini, J. D., De, A. K., Kodys, K., Silva, W. E., Miller, C. L. (1998) Both T-helper-1-and T-helper-2-type lymphokines are depressed in posttrauma anergy. J. Trauma 44, 1037-1045.
13. De, A. K., Kodys, K M., Pellegrini, J., Yeh, B., Furse, R. K, Bankey, P., Miller-Graziano, C. L. (2000) Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunode-pression. Clin. Immunol. 96, 52-66.
14. Ninnemann, J. L., Stein, M. D. (1980) Bacterial endotoxin and the generation of suppressor T cells following thermal injury. J. Trauma 20, 959-966.
15. Suzuki, F., Pollard, R. B. (1982) Mechanism for the suppression of γ-interferon responsiveness in mice after thermal injury. J. Immunol. 129, 1811-1815.
16. Kupper, T. S., Green, D. R. (1984) Immunoregulation after thermal injury: sequential appearance of I-J +, Ly-1 T suppressor inducer cells and Ly-2 T suppressor effector cells following thermal trauma in mice. J. Immunol. 133, 3047-3053.
17. O'Mahony, J. B., Palder, S. B., Wood, J. J., McIrvine, A., Rodrick, M. L., Demling, R. H., Mannick, J. A. (1984) Depression of cellular immunity after multiple trauma in the absence of sepsis. J. Trauma 24, 869-875.
18. Calvano, S. E., deRiesthal, H. F., Marano, M. A., Antonacci, A. C. (1988) The decrease in peripheral blood CD4+ T cells following thermal injury in humans can be accounted for by a concomitant decrease in suppressor-inducer CD4+ T cells as assessed using anti-CD45R. Clin. Immunol. Immunopathol. 47, 164-173.
19. Lederer, J. A., Rodrick, M. L., Mannick, J. A. (1999) The effects of injury on the adaptive immune response. Shock 11, 153-159.
20. MacConmara, M. P., Maung, A. A., Fujimi, S., McKenna, A. M., Delisle, A., Lapchak, P. H., Rogers, S., Lederer, J. A., Mannick, J. A. (2006) Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann. Surg. 244, 514-523.
21. Venet, F., Chung, C. S., Monneret, G., Huang, X., Horner, B., Garber, M., Ayala, A. (2008) Regulatory T cell populations in sepsis and trauma. J. Leukoc. Biol. 83, 523-535.
22. Wolfe, J. H., Wu, A. V., O'Connor, N. E., Saporoschetz, I., Mannick, J. A. (1982) Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch. Surg. 117, 1266-1271.
23. Guo, Z., Kavanagh, E., Zang, Y., Dolan, S. M., Kriynovich, S. J., Mannick, J. A., Lederer, J. A. (2003) Burn injury promotes antigen-driven Th2-type responses in vivo. J. Immunol. 171, 3983-3990.
24. Ni Choileain, N., MacConmara, M., Zang, Y., Murphy, T. J., Mannick, J. A., Lederer, J. A. (2006) Enhanced regulatory T cell activity is an element of the host response to injury. J. Immunol. 176, 225-236.
25. O'Leary, F. M., Tajima, G., Delisle, A. J., Ikeda, K, Dolan, S. M., Han-schen, M., Mannick, J. A., Lederer, J. A. (2011) Injury-induced GR-1 + macrophage expansion and activation occurs independent of CD4 T cell influence. Shock 36, 162-169.
26. Noel, J. G., Guo, X., Wells-Byrum, D., Schwemberger, S., Caldwell, C. C., Ogle, C. K. (2005) Effect of thermal injury on splenic myelopoi-esis. Shock 23, 115-122.
27. Van Rompaey, N., Le Moine, A. (2011) Myeloid-derived suppressor cells: characterization and expansion in models of endotoxemia and transplantation. Methods Mol. Biol. 677, 169-180.
28. Atochina, O., Daly-Engel, T., Piskorska, D., McGuire, E., Harn, D. A. (2001) A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-γ and nitric oxide-dependent mechanism. J. Immunol. 167, 4293-4302.
29. Gomez-Garcia, L., Lopez-Marin, L. M., Saavedra, R., Reyes, J. L., Rodri-guez-Sosa, M., Terrazas, L. I. (2005) Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells. Parasite Immunol. 27, 395-405.
30. Hegde, V. L., Nagarkatti, M., Nagarkatti, P. S. (2010) Cannabinoid receptor activation leads to massive mobilization of myeloid-derived sup pressor cells with potent immunosuppressive properties. Eur. J. Immunol. 40, 3358-3371.
31. Coleman, C. N., Hrdina, C., Bader, J. L., Norwood, A., Hayhurst, R., Forsha, J., Yeskey, K, Knebel, A. (2009) Medical response to a radiologic/nuclear event: integrated plan from the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services. Ann. Emerg. Med. 53, 213-222.
32. Oppenheim, J. J., Tewary, P., de la Rosa, G., Yang, D. (2007) Alarmins initiate host defense. Adv. Exp. Med. Biol. 601, 185-194.
33. Oppenheim, J. J., Yang, D. (2005) Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365.
34. Matzinger, P. (2002) An innate sense of danger. Ann. N. Y. Acad. Sci. 961, 341-342.
35. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
36. Alverdy, J. C., Chang, E. B. (2008) The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away. J. Leukoc. Biol. 83, 461-466.
37. Bianchi, M. E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
38. Seong, S. Y., Matzinger, P. (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478.
39. Mollen, K P., Levy, R. M., Prince, J. M., Hoffman, R. A., Scott, M. J., Kaczorowski, D. J., Vallabhaneni, R., Vodovotz, Y., Billiar, T. R. (2008) Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells. J. Leukoc. Biol. 83, 80-88.
40. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. Y., Strassheim, D., Ishizaka, A., Abraham, E. (2004) Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377.
41. Qin, S., Wang, H., Yuan, R., Li, H., Ochani, M., Ochani, K, Rosas-Bal-lina, M., Czura, C. J., Huston, J. M., Miller, E., Lin, X., Sherry, B., Kumar, A., Larosa, G., Newman, W., Tracey, K J., Yang, H. (2006) Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203, 16371642.
42. Cohen, M.J., Brohi, K., Calfee, C. S., Rahn, P., Chesebro, B. B., Christiaans, S. C., Carles, M., Howard, M., Pittet, J. F. (2009) Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit. Care 13, R174.
43. Yang, H., Hreggvidsdottir, H. S., Palmblad, K, Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., Akira, S., Bier-haus, A., Erlandsson-Harris, H., Andersson, U., Tracey, K J. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. USA 107, 11942-11947.
44. Goldstein, R. S., Bruchfeld, A., Yang, L., Qureshi, A. R., Gallowitsch-Puerta, M., Patel, N. B., Huston, B. J., Chavan, S., Rosas-Ballina, M., Gregersen, P. K, Czura, C. J., Sloan, R. P., Sama, A. E., Tracey, K J. (2007) Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13, 210-215.
45. Yan, W., Chang, Y., Liang, X., Cardinal, J. S., Huang, H., Thorne, S. H., Monga, S. P., Geller, D. A., Lotze, M. T., Tsung, A. (2012) High mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology 55, 1863-1875.
46. Han, J., Zhong, J., Wei, W., Wang, Y., Huang, Y., Yang, P., Purohit, S., Dong, Z., Wang, M. H., She, J. X., Gong, F., Stern, D. M., Wang, C. Y. (2008) Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 57, 2118-2127.
47. Yang, D., Postnikov, Y. V., Li, Y., Tewary, P., de la Rosa, G., Wei, F., Klinman, D., Gioannini, T., Weiss, J. P., Furusawa, T., Bustin, M., Op-penheim, J. J. (2012) High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J. Exp. Med. 209, 157-171.
48. Mathur, S., Walley, K R., Wang, Y., Indrambarya, T., Boyd, J. H. (2011) Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ. J. 75, 24452452.
49. Baker, T. A., Romero, J., Bach IV, H. H., Strom, J. A., Gamelli, R. L., Majetschak, M. (2012) Systemic release of cytokines and heat shock proteins in porcine models of polytrauma and hemorrhage. Crit. Care Med. 40, 876-885.
50. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K, Itagaki, K, Hauser, C. J. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107.
51. Gasse, P., Riteau, N., Charron, S., Girre, S., Fick, L., Petrilli, V., Tschopp, J., Lagente, V., Quesniaux, V. F., Ryffel, B., Couillin, I. (2009) Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 179, 903-913.
52. Kono, H., Chen, C. J., Ontiveros, F., Rock, K L. (2010) Uric acid promotes an acute inflammatory response to sterile cell death in mice. J. Clin. Invest. 120, 1939-1949.
53. Chen, C. J., Shi, Y., Hearn, A., Fitzgerald, K., Golenbock, D., Reed, G., Akira, S., Rock, K. L. (2006) MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116, 2262-2271.
54. Riteau, N., Gasse, P., Fauconnier, L., Gombault, A., Couegnat, M., Fick, L., Kanellopoulos, J., Quesniaux, V. F., Marchand-Adam, S., Crestani, B., Ryffel, B., Couillin, I. (2010) Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am. J. Re spir. Crit. Care Med. 182, 774-783.
55. Ehrchen, J. M., Sunderkotter, C., Foell, D., Vogl, T., Roth, J. (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calpro-tectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 86, 557-566.
56. Manson, J., Thiemermann, C., Brohi, K (2012) Trauma alarmins as activators of damage-induced inflammation. Br. J. Surg. 99 (Suppl. 1), 12-20.
57. Tsan, M. F., Baochong, G. (2007) Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J. Endotoxin Res. 13, 6-14.
58. Rouhiainen, A., Tumova, S., Valmu, L., Kalkkinen, N., Rauvala, H. (2007) Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J. Leukoc. Biol. 81, 49-58.
59. Sha, Y., Zmijewski, J., Xu, Z., Abraham, E. (2008) HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180, 2531-2537.
60. Tsan, M-F. (2011) Heat shock proteins and high mobility group box 1 protein lack cytokine function. J. Leukoc. Biol. 89, 847-853.
61. Bendz, H., Ruhland, S. C., Pandya, M. J., Hainzl, O., Riegelsberger, S., Brauchle, C., Mayer, M. P., Buchner, J., Issels, R. D., Noessner, E. (2007) Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling. J. Biol. Chem. 282, 31688-31702.
62. Fan, J., Li, Y., Levy, R. M., Fan, J. J., Hackam, D. J., Vodovotz, Y., Yang, H., Tracey, K J., Billiar, T. R., Wilson, M. A. (2007) Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J. Immunol. 178, 6573-6580.
63. Goldstein, R. S., Gallowitsch-Puerta, M., Yang, L., Rosas-Ballina, M., Huston, J. M., Czura, C.J., Lee, D. C., Ward, M. F., Bruchfeld, A. N., Wang, H., Lesser, M. L., Church, A. L., Litroff, A. H., Sama, A. E., Tracey, K J. (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25, 571-574.
64. Yang, H., Wang, H., Czura, C. J., Tracey, K. J. (2002) HMGB1 as a cytokine and therapeutic target. J. Endotoxin Res. 8, 469-472.
65. Van Beijnum, J. R., Buurman, W. A., Griffioen, A. W. (2008) Convergence and amplification of Toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11, 91-99.
66. Tsan, M. F., Gao, B. (2004) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514-519.
67. Gao, B., Tsan, M. F. (2003) Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor a release by murine macrophages. J. Biol. Chem. 278, 174-179.
68. Ueki, K., Tabeta, K., Yoshie, H., Yamazaki, K. (2002) Self-heat shock protein 60 induces tumour necrosis factor-a in monocyte-derived macrophage: possible role in chronic inflammatory periodontal disease. Clin. Exp. Immunol. 127, 72-77.
69. Maung, A. A., Fujimi, S., M, L. M., Macconmara, M. P., Mannick, J. A., Lederer, J. A. (2005) Enhanced TLR4 reactivity following injury is mediated by increased p38 activation. J. Leukoc. Biol.78, 565-573.
70. Beffa, D. C., Fischman, A. J., Fagan, S. P., Hamrahi, V. F., Paul, K. W., Kaneki, M., Yu, Y. M., Tompkins, R. G., Carter, E. A. (2011) Simvastatin treatment improves survival in a murine model of burn sepsis: role of interleukin 6. Burns 37, 222-226.
71. Schwacha, M. G., Chung, C. S., Ayala, A., Bland, K I., Chaudry, I. H. (2002) Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury. Am. J. Physiol. Cell Physiol. 282, C263-C270.
72. Sauaia, A., Moore, F. A., Moore, E. E., Lezotte, D. C. (1996) Early risk factors for postinjury multiple organ failure. World J. Surg. 20, 392-400.
73. Partrick, D. A., Moore, F. A., Moore, E. E., Barnett C. C., Jr., Silliman, C. C. (1996) Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz. 4, 194-210.
74. Wu, J. Z., Ogle, C. K., Mao, J. X., Szczur, K., Fischer, J. E., Ogle, J. D. (1995) The increased potential for the production of inflammatory cytokines by Kupffer cells and splenic macrophages eight days after thermal injury. Inflammation 19, 529-541.
75. Schwacha, M. G. (2003) Macrophages and post-burn immune dysfunction. Burns 29, 1-14.
76. Schwacha, M. G., Schneider, C. P., Bland, K I., Chaudry, I. H. (2001) Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am. J. Physiol. Cell Physiol. 281, C1180-C1187.
77. Makarenkova, V. P., Bansal, V., Matta, B. M., Perez, L. A., Ochoa, J. B. (2006) CD11b + /Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176, 2085-2094.
78. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Di-vino, C. M., Chen, S. H. (2006) Gr-1 + CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 11231131.
79. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K M., O'Malley, K A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., Swan, R., Chung, C-S., Atkinson, M. A., Ramphal, R., Gabrilovich, D. I., Reeves, W. H., Ayala, A., Phillips, J., LaFace, D., Hey-worth, P. G., Clare-Salzler, M., Moldawer, L. L. (2007) MyD88-depen-dent expansion of an immature GR-1 + CD11b+ population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 14631474.
80. Noel, G., Guo, X., Wang, Q., Schwemberger, S., Byrum, D., Ogle, C. (2007) Postburn monocytes are the major producers of TNF-a in the heterogeneous splenic macrophage population. Shock 27, 312-319.
81. Mommsen, P., Barkhausen, T., Frink, M., Zeckey, C., Probst, C., Krettek, C., Hildebrand, F. (2011) Productive capacity of alveolar macrophages and pulmonary organ damage after femoral fracture and hemorrhage in IL-6 knockout mice. Cytokine 53, 60-65.
82. Kigerl, K A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., Popovich, P. G. (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435-13444.
83. Frink, M., Hsieh, Y. C., Thobe, B. M., Choudhry, M. A., Schwacha, M. G., Bland, K I., Chaudry, I. H. (2007) TLR4 regulates Kupffer cell chemokine production, systemic inflammation and lung neutrophil infiltration following trauma-hemorrhage. Mol. Immunol. 44, 26252630.
84. Kirchhoff, C., Biberthaler, P., Mutschler, W. E., Faist, E., Jochum, M., Zedler, S. (2009) Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a prospective cohort study. Crit. Care 13, R88.
85. Fabian, T. C., Croce, M. A., Fabian, M. J., Trenthem, L. L., Yockey, J. M., Boscarino, R., Proctor, K G. (1995) Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: experimental results and clinical correlation. Surgery 118, 63-72.
86. Xiao, W., Mindrinos, M. N., Seok, J., Cuschieri, J., Cuenca, A. G., Gao, H., Hayden, D. L., Hennessy, L., Moore, E. E., Minei, J. P., Bankey, P. E., Johnson, J. L., Sperry, J., Nathens, A. B., Billiar, T. R., West, M. A., Brownstein, B. H., Mason, P. H., Baker, H. V., Finnerty, C. C., Jeschke, M. G., Lopez, M. C., Klein, M. B., Gamelli, R. L., Gibran, N. S., Arnoldo, B., Xu, W., Zhang, Y., Calvano, S. E., McDonald-Smith, G. P., Schoenfeld, D. A., Storey, J. D., Cobb, J. P., Warren, H. S., Moldawer, L. L., Herndon, D. N., Lowry, S. F., Maier, R. V., Davis, R. W., Tompkins, R. G. (2011) A genomic storm in critically injured humans. J. Exp. Med. 208, 2581-2590.
87. Osuka, A, Hanschen, M., Stoecklein, V., Lederer, J. A. (2012) A protective role for inflammasome activation following injury. Shock 37, 47-55.
88. Menzel, C. L., Sun, Q., Loughran, P. A., Pape, H. C., Billiar, T. R., Scott, M. J. (2011) Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol. Med. 17, 1031-1038.
89. Beutler, B., Rehli, M. (2002) Evolution of the TIR, Tolls and TLRs: functional inferences from computational biology. Curr. Top. Microbiol. Immunol. 270, 1-21.
90. Kawai, T., Akira, S. (2007) TLR signaling. Semin. Immunol. 19, 24-32.
91. Mandrekar, P., Szabo, G. (2009) Signalling pathways in alcohol-induced liver inflammation. J. Hepatol. 50, 1258-1266.
92. Bruns, B., Maass, D., Barber, R., Horton, J., Carlson, D. (2008) Alterations in the cardiac inflammatory response to burn trauma in mice lacking a functional Toll-like receptor 4 gene. Shock 30, 740-746.
93. Zhang, B., Ramesh, G., Uematsu, S., Akira, S., Reeves, W. B. (2008) TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J. Am. Soc. Nephrol. 19, 923-932.
94. Thobe, B. M., Frink, M., Hildebrand, F., Schwacha, M. G., Hubbard, W. J., Choudhry, M. A., Chaudry, I. H. (2007) The role ofMAPKin Kupffer cell Toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J. Cell. Physiol. 210, 667-675.
95. Triantafilou, M., Lepper, P. M., Briault, C. D., Ahmed, M. A., Dmo-chowski, J. M., Schumann, C., Triantafilou, K (2008) Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide "sensing apparatus". Eur. J. Immunol. 38, 192-203.
96. Abbas, A. K, Murphy, K M., Sher, A. (1996) Functional diversity of helper T lymphocytes. Nature 383, 787-793.
97. Murphy, K. M., Reiner, S. L. (2002) The lineage decisions of helper T cells. Nat. Rev. Immunol. 2, 933-944.
98. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., Murphy, K. M. (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688.
99. Pepper, M., Jenkins, M. K (2011) Origins of CD4(+) effector and central memory T cells. Nat. Immunol. 12, 467-471.
100. Zedler, S., Bone, R. C., Baue, A. E., von Donnersmarck, G. H., Faist, E. (1999) T-cell reactivity and its predictive role in immunosuppression after burns. Crit. Care Med. 27, 66-72.
101. Faunce, D. E., Gamelli, R. L., Choudhry, M. A., Kovacs, E. J. (2003) A role for CD1d-restricted NKT cells in injury-associated T cell suppression. J. Leukoc. Biol. 73, 747-755.
102. Pinheiro, H. S., Camara, N. O., Noronha, I. L., Maugeri, I. L., Franco, M. F., Medina, J. O., Pacheco-Silva, A. (2007) Contribution of CD4+ T cells to the early mechanisms of ischemia-reperfusion injury in a mouse model of acute renal failure. Braz. J. Med. Biol. Res. 40, 557-568.
103. Kelly, J. L., O'Suilleabhain, C. B., Soberg, C. C., Mannick, J. A., Le-derer, J. A. (1999) Severe injury triggers antigen-specific T-helper cell dysfunction. Shock 12, 39-45.
104. Murphy, T., Paterson, H., Rogers, S., Mannick, J. A., Lederer, J. A. (2003) Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients. Ann. Surg. 238, 401-410.
105. O'Sullivan, S. T., Lederer, J. A., Horgan, A. F., Chin, D. H., Mannick, J. A., Rodrick, M. L. (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222, 482-490.
106. Mack, V. E., McCarter, M. D., Naama, H. A., Calvano, S. E., Daly, J. M. (1997) Candida infection following severe trauma exacerbates Th2 cytokines and increases mortality. J. Surg. Res. 69, 399-407.
107. Yeh, S. H., Chuang, H., Lin, L. W., Hsiao, C. Y., Wang, P. W., Liu, R. T., Yang, K. D. (2009) Regular Tai Chi Chuan exercise improves T cell helper function of patients with type 2 diabetes mellitus with an increase in T-bet transcription factor and IL-12 production. Br. J. Sports Med. 43, 845-850.
108. Wang, J., Song, H., Tang, X., Yang, Y., Vieira, V. J., Niu, Y., Ma, Y. (2011) Effect of exercise training intensity on murine T-regulatory cells and vaccination response. Scand. J. Med. Sci. Sports, Epub ahead of print.
109. Mack, V. E., McCarter, M. D., Naama, H. A., Calvano, S. E., Daly, J. M. (1996) Dominance of T-helper 2-type cytokines after severe injury. Arch. Surg. 131, 1303-1308.
110. Navarro-Zorraquino, M., Lozano, R., Deus, J., Pastor, C., Larrad, L., Tejero, E., Roman, J., Palacios, M. J., Torcal, J., Salinas, J. C. (2001) Determination of the immunoglobulin E postoperative variation as a measure of surgical injury. World J. Surg. 25, 585-591.
111. Miyara, M., Sakaguchi, S. (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13, 108-116.
112. Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., Nomura, T. (2006) Foxp3+ CD25+ CD4 + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27.
113. Aschenbrenner, K, D'Cruz, L. M., Vollmann, E. H., Hinterberger, M., Emmerich, J., Swee, L. K, Rolink, A., Klein, L. (2007) Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire + medullary thymic epithelial cells. Nat. Immunol. 8, 351-358.
114. Fohse, L., Suffner, J., Suhre, K, Wahl, B., Lindner, C., Lee, C. W., Schmitz, S., Haas, J. D., Lamprecht, S., Koenecke, C., Bleich, A., Ham-merling, G. J., Malissen, B., Suerbaum, S., Forster, R., Prinz, I. (2011) High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells. Eur. J. Immunol. 41, 3101-3113.
115. Pakravan, N., Hassan, A. T., Hassan, Z. M. (2007) Naturally occurring self-reactive CD4 + CD25+ regulatory T cells: universal immune code. Cell. Mol. Immunol. 4, 197-201.
116. Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A., Caton, A. J. (2001) Thymic selection of CD4 + CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306.
117. Hsieh, C. S., Liang, Y., Tyznik, A. J., Self, S. G., Liggitt, D., Rudensky, A. Y. (2004) Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267-277.
118. Fontenot, J. D., Gavin, M. A., Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
119. Lahl, K, Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., Wagner, H., Huehn, J., Sparwasser, T. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57-63.
120. Chang, X., Gao, J. X., Jiang, Q., Wen, J., Seifers, N., Su, L., Godfrey, V. L., Zuo, T., Zheng, P., Liu, Y. (2005) The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J. Exp. Med. 202, 1141-1151.
121. Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F., Ziegler, S. F. (2001) Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672-37679.
122. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleis-chhauer, K, Levings, M. K (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50.
123. Maloy, K J., Antonelli, L. R., Lefevre, M., Powrie, F. (2005) Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells. Immunol. Lett. 97, 189-192.
124. Maloy, K J., Powrie, F. (2001) Regulatory T cells in the control of immune pathology. Nat. Immunol. 2, 816-822.
125. Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F., Wood, K. J. (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796.
126. Thornton, A. M., Shevach, E. M. (1998) CD4 + CD25+ immunoregula-tory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296.
127. Jutel, M., Akdis, M., Budak, F., Aebischer-Casaulta, C., Wrzyszcz, M., Blaser, K, Akdis, C. A. (2003) IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33, 1205-1214.
128. Tang, Q., Boden, E. K, Henriksen, K J., Bour-Jordan, H., Bi, M., Blue-stone, J. A. (2004) Distinct roles of CTLA-4 and TGF-β in CD4 + CD25+ regulatory T cell function. Eur. J. Immunol. 34, 29963005.
129. Greenwald, R. J., Latchman, Y. E., Sharpe, A. H. (2002) Negative coreceptors on lymphocytes. Curr. Opin. Immunol. 14, 391-396.
130. Chen, X., Subleski, J. J., Kopf, H., Howard, O. M., Mannel, D. N., Op-penheim, J. J. (2008) Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4 + CD25 + FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J. Immunol. 180, 6467-6471.
131. Purcell, E. M., Dolan, S. M., Kriynovich, S., Mannick, J. A., Lederer, J. A. (2006) Burn injury induces an early activation response by lymph node cd4+ T cells. Shock 25, 135-140.
132. Hanschen, M., Tajima, G., O'Leary, F., Ikeda, K, Lederer, J. A. (2011) Injury induces early activation of T-cell receptor signaling pathways in CD4+ regulatory T cells. Shock 35, 252-257.
133. Sansom, D. M., Walker, L. S. (2006) The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 212, 131-148.
134. Herman, A. E., Freeman, G. J., Mathis, D., Benoist, C. (2004) CD4 + CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199, 14791489.
135. Gotsman, I., Grabie, N., Gupta, R., Dacosta, R., MacConmara, M., Le-derer, J., Sukhova, G., Witztum, J. L., Sharpe, A. H., Lichtman, A. H. (2006) Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114, 2047-2055.
136. Tang, Q., Henriksen, K J., Boden, E. K, Tooley, A. J., Ye, J., Subudhi, S. K, Zheng, X. X., Strom, T. B., Bluestone, J. A. (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4 + CD25+ regulatory T cells. J. Immunol. 171, 3348-3352.
137. Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., Bluestone, J. A. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4 + CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440.
138. Venet, F., Pachot, A., Debard, A. L., Bohe, J., Bienvenu, J., Lepape, A., Monneret, G. (2004) Increased percentage of CD4 + CD25+ regulatory T cells during septic shock is due to the decrease of CD4 + CD25-lymphocytes. Crit. Care Med. 32, 2329-2331.
139. Guignant, C., Lepape, A., Huang, X., Kherouf, H., Denis, L., Poitevin, F., Malcus, C., Cheron, A., Allaouchiche, B., Gueyffier, F., Ayala, A., Monneret, G., Venet, F. (2011) Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit. Care 15, R99.
140. MacConmara, M. P., Tajima, G., O'Leary, F., Delisle, A. J., McKenna, A. M., Stallwood, C. G., Mannick, J. A., Lederer, J. A. (2011) Regulatory T cells suppress antigen-driven CD4 T cell reactivity following injury. J. Leukoc. Biol. 89, 137-147.
141. Zang, Y., Dolan, S. M., Choileain, N. N., Kriynovich, S. J., Murphy, T. J., Sayles, P., Mannick, J. A., Lederer, J. A. (2004) Burn injury initiates a shift in superantigen-induced T cell responses and host survival. J. Immunol. 172, 4883-4892.
142. Caretto, D., Katzman, S. D., Villarino, A. V., Gallo, E., Abbas, A. K. (2010) Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells. J. Immunol. 184, 30-34.
143. Izcue, A., Coombes, J. L., Powrie, F. (2006) Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271.
144. Matsumoto, Y., Sakuma, H., Kohyama, K, Park, I. K (2007) Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis. J. Neuroimmunol. 187, 44-54.
145. Yu, P., Gregg, R. K., Bell, J.J., Ellis, J. S., Divekar, R., Lee, H. H., Jain, R., Waldner, H., Hardaway, J. C., Collins, M., Kuchroo, V. K, Zagh-ouani, H. (2005) Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 174, 6772-6780.
146. Kumar, V., Stellrecht, K, Sercarz, E. (1996) Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 184, 16091617.
147. Murphy, T. J., Ni Choileain, N., Zang, Y., Mannick, J. A., Lederer, J. A. (2005) CD4 + CD25+ regulatory T cells control innate immune reactivity after injury. J. Immunol. 174, 2957-2963.
148. Lee, J. H., Wang, L. C., Lin, Y. T., Yang, Y. H., Lin, D. T., Chiang, B. L. (2006) Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117, 280-286.
149. Chavele, K. M., Ehrenstein, M. R. (2011) Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett. 585, 36033610.
150. Monneret, G., Debard, A. L., Venet, F., Bohe, J., Hequet, O., Bienvenu, J., Lepape, A. (2003) Marked elevation of human circulating CD4 + CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31, 2068-2071.
151. Scumpia, P. O., Delano, M.J., Kelly, K M., O'Malley, K. A., Efron, P. A., McAuliffe, P. F., Brusko, T., Ungaro, R., Barker, T., Wynn, J. L., Atkinson, M. A., Reeves, W. H., Salzler, M. J., Moldawer, L. L. (2006) Increased natural CD4 + CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J. Immunol. 177, 7943-7949.
152. Wisnoski, N., Chung, C. S., Chen, Y., Huang, X., Ayala, A. (2007) The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27, 251-257.
153. Heuer, J. G., Zhang, T., Zhao, J., Ding, C., Cramer, M., Justen, K L., Vonderfecht, S. L., Na, S. (2005) Adoptive transfer of in vitro-stimu-lated CD4 + CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J. Immunol. 174, 7141-7146.
154. Abraham, E., Laterre, P. F., Garbino, J., Pingleton, S., Butler, T., Dug-ernier, T., Margolis, B., Kudsk, K, Zimmerli, W., Anderson, P., Reyn-aert, M., Lew, D., Lesslauer, W., Passe, S., Cooper, P., Burdeska, A., Modi, M., Leighton, A., Salgo, M., Van der Auwera, P. (2001) Lener-cept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit. Care Med. 29, 503-510.
155. Paine III, R., Standiford, T. J., Dechert, R. E., Moss, M., Martin, G. S., Rosenberg, A. L., Thannickal, V. J., Burnham, E. L., Brown, M. B., Hyzy, R. C. (2012) A randomized trial of recombinant human granulo-cyte-macrophage colony stimulating factor for patients with acute lung injury. Crit. Care Med. 40, 90-97.
156. Bo, L., Wang, F., Zhu, J., Li, J., Deng, X. (2011) Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit. Care 15, R58.
157. O'Suilleabhain, C., O'Sullivan, S. T., Kelly, J. L., Lederer, J., Mannick, J. A., Rodrick, M. L. (1996) Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 120, 290296.
158. Kobayashi, H., Kobayashi, M., Utsunomiya, T., Herndon, D. N., Pollard, R. B., Suzuki, F. (1999) Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J. Immunol. 162, 7148-7154.
159. Goebel, A., Kavanagh, E., Lyons, A., Saporoschetz, I. B., Soberg, C., Lederer, J. A., Mannick, J. A., Rodrick, M. L. (2000) Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann. Surg. 231, 253-261.
160. Leonard, J. P., Sherman, M. L., Fisher, G. L., Buchanan, L. J., Larsen, G., Atkins, M. B., Sosman, J. A., Dutcher, J. P., Vogelzang, N.J., Ryan, J. L. (1997) Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-7 production. Blood 90, 25412548.
161. Cheever, M. A. (2008) Twelve immunotherapy drugs that could cure cancers. Immunol. Rev. 222, 357-368.
162. Kinoshita, M., Kuranaga, N., Matsumoto, A., Ono, S., Shinomiya, N., Hiraide, H., Seki, S. (2006) Multiple interleukin-18 injections promote both mouse Th1 and Th2 responses after sublethal Escherichia coli infection. Clin. Exp. Immunol. 143, 41-49.
163. Kelly, J. L., Lyons, A., Soberg, C. C., Mannick, J. A., Lederer, J. A. (1997) Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. Surgery 122, 146-152.
164. Lyons, A., Goebel, A., Mannick, J. A., Lederer, J. A. (1999) Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch. Surg. 134, 1317-1323.
165. Watowich, S. S., Liu, Y. J. (2010) Mechanisms regulating dendritic cell specification and development. Immunol. Rev. 238, 76-92.
166. Kawasaki, T., Choudhry, M. A., Schwacha, M. G., Bland, K I., Chaudry, I. H. (2009) Effect of interleukin-15 on depressed splenic dendritic cell functions following trauma-hemorrhage. Am. J. Physiol. Cell Physiol. 296, C124-C130.
167. Toliver-Kinsky, T. E., Cui, W., Murphey, E. D., Lin, C., Sherwood, E. R. (2005) Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection. J. Immunol. 174, 404-410.
168. Toliver-Kinsky, T. E., Lin, C. Y., Herndon, D. N., Sherwood, E. R. (2003) Stimulation of hematopoiesis by the fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice. Infect. Immun. 71, 3058-3067.
169. Bohannon, J., Cui, W., Cox, R., Przkora, R., Sherwood, E., Toliver-Kin-sky, T. (2008) Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection. J. Immunol. 180, 3038-3048.
170. Clond, M. A., Mirocha, J., Singer, M. B., Bukur, M., Salim, A., Mar-guiles, D. R., Ley, E. J. (2011) Gender influences outcomes in trauma patients with elevated systolic blood pressure. Am. J. Surg. 202, 823827.
171. Magnotti, L. J., Fischer, P. E., Zarzaur, B. L., Fabian, T. C., Croce, M. A. (2008) Impact of gender on outcomes after blunt injury: a definitive analysis of more than 36,000 trauma patients. J. Am. Coll. Surg. 206, 984-991.
172. Sperry, J. L., Minei, J. P. (2008) Gender dimorphism following injury: making the connection from bench to bedside. J. Leukoc. Biol. 83, 499506.
173. Knoferl, M. W., Angele, M. K, Diodato, M. D., Schwacha, M. G., Ayala, A., Cioffi, W. G., Bland, K. I., Chaudry, I. H. (2002) Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann. Surg. 235, 105-112.
174. Yokoyama, Y., Kuebler, J. F., Matsutani, T., Schwacha, M. G., Bland, K I., Chaudry, I. H. (2003) Mechanism of the salutary effects of 17β-estradiol following trauma-hemorrhage: direct downregulation of Kupffer cell proinflammatory cytokine production. Cytokine 21, 91-97.
175. Chaudry, I. H., Samy, T. S., Schwacha, M. G., Wang, P., Rue III, L. W., Bland, K I. (2003) Endocrine targets in experimental shock. J. Trauma 54, S118-S125.
176. Gomez, C. R., Plackett, T. P., Kovacs, E. J. (2007) Aging and estrogen: modulation of inflammatory responses after injury. Exp. Gerontol. 42, 451-456.
177. Suzuki, T., Kawasaki, T., Choudhry, M. A., Chaudry, I. H. (2011) Role of PPAR7 in the salutary effects of l7β-estradiol on Kupffer cell cytokine production following trauma-hemorrhage. J. Cell. Physiol. 226, 205-211.
178. Wigginton, J. G., Pepe, P. E., Idris, A. H. (2010) Rationale for routine and immediate administration of intravenous estrogen for all critically ill and injured patients. Crit. Care Med. 38, S620-S629.
179. Kurmis, R., Parker, A., Greenwood, J. (2010) The use of immunonutri-tion in burn injury care: where are we? J. Burn Care Res. 31, 677-691.
180. Zhou, Y. P., Jiang, Z. M., Sun, Y. H., Wang, X. R., Ma, E. L., Wilmore, D. (2003) The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, doubleblind, controlled clinical trial. JPENJ. Parenter. Enteral Nutr. 27, 241245.